Literature DB >> 15880586

Subtype-specific expression and genetic alterations of the chemokinereceptor gene CXCR4 in medulloblastomas.

Ulrich Schüller1, Arend Koch, Wolfgang Hartmann, Maria L Garrè, Cynthia G Goodyer, Armando Cama, Niels Sörensen, Otmar D Wiestler, Torsten Pietsch.   

Abstract

Recent findings indicate that the chemokine receptor Cxcr4 is essential for normal development of the cerebellar cortex. As medulloblastomas (MBs), the most common malignant brain tumors of childhood, are believed to arise from neuronal cerebellar precursors, we asked whether there is a potential role for Cxcr4 in the pathogenesis of MB. RT-PCR and immunohistochemistry revealed expression of Cxcr4 in different variants of MBs. Whereas 18/20 classic MBs showed very low levels of CXCR4 mRNA, high amounts were expressed in 17/18 desmoplastic and 6/7 extensively nodular MBs. In addition, a significant correlation of high CXCR4 mRNA levels and presence of the neurotrophin receptor p75NTR or expression of ATOH1 and GLI1 suggests that CXCR4 is a reliable marker for tumors derived from the cerebellar external granular layer. Because Cxcr4 is important for migration and cell cycle control of granular precursors, we screened for mutations in the coding region by SSCP and gene sequencing. In a series of 90 MBs and 8 MB cell lines, we found one germline and one somatic mutation resulting in amino acid substitutions in the first (Ile53Leu) and second (Asp97Asn) transmembrane regions, respectively. These data suggest that Cxcr4 may be involved in the pathogenesis of MBs. Copyright (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15880586     DOI: 10.1002/ijc.21116

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

1.  Heterologous regulation of CXCR4 lysosomal trafficking.

Authors:  Adriana Caballero; Sarah A Mahn; Mudassir S Ali; M Rose Rogers; Adriano Marchese
Journal:  J Biol Chem       Date:  2019-04-01       Impact factor: 5.157

Review 2.  Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology.

Authors:  Meizhang Li; Richard M Ransohoff
Journal:  Prog Neurobiol       Date:  2007-11-26       Impact factor: 11.685

3.  NMR metabolomics of MTLn3E breast cancer cells identifies a role for CXCR4 in lipid and choline regulation.

Authors:  Louic S Vermeer; Gilbert O Fruhwirth; Pahini Pandya; Tony Ng; A James Mason
Journal:  J Proteome Res       Date:  2012-04-02       Impact factor: 4.466

4.  CXCR4 activation defines a new subgroup of Sonic hedgehog-driven medulloblastoma.

Authors:  Rajarshi Sengupta; Adrian Dubuc; Stacey Ward; Lihua Yang; Paul Northcott; B Mark Woerner; Kirsten Kroll; Jingqin Luo; Michael D Taylor; Robert J Wechsler-Reya; Joshua B Rubin
Journal:  Cancer Res       Date:  2011-11-03       Impact factor: 12.701

5.  Development and characterization of murine models of medulloblastoma extraneural growth in bone.

Authors:  Jessica M Grunda; Dezhi Wang; Gregory A Clines
Journal:  Clin Exp Metastasis       Date:  2013-03-15       Impact factor: 5.150

Review 6.  Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective.

Authors:  Judith M de Bont; Roger J Packer; Erna M Michiels; Monique L den Boer; Rob Pieters
Journal:  Neuro Oncol       Date:  2008-08-01       Impact factor: 12.300

7.  A novel role of HLA class I in the pathology of medulloblastoma.

Authors:  Courtney Smith; Mariarita Santi; Bhargavi Rajan; Elisabeth J Rushing; Mi Rim Choi; Brian R Rood; Robert Cornelison; Tobey J MacDonald; Stanislav Vukmanovic
Journal:  J Transl Med       Date:  2009-07-12       Impact factor: 5.531

8.  Protein kinase A regulatory subunit distribution in medulloblastoma.

Authors:  Carla Mucignat-Caretta; Luca Denaro; Marco Redaelli; Domenico D'Avella; Antonio Caretta
Journal:  BMC Cancer       Date:  2010-04-14       Impact factor: 4.430

9.  Defining a role for Sonic hedgehog pathway activation in desmoplastic medulloblastoma by identifying GLI1 target genes.

Authors:  Joon Won Yoon; Richard Gilbertson; Stephen Iannaccone; Philip Iannaccone; David Walterhouse
Journal:  Int J Cancer       Date:  2009-01-01       Impact factor: 7.396

Review 10.  Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors.

Authors:  Hyunsuk Shim; Shinya Oishi; Nobutaka Fujii
Journal:  Semin Cancer Biol       Date:  2008-11-25       Impact factor: 15.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.